Back to search

Article

Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer’s models

2026-01-21

Abstract excerpt

Alzheimer’s disease (AD) remains without effective disease-modifying therapies, underscoring the need for interventions that target interconnected molecular and cellular processes driving cognitive decline. Leveraging a cross-species translational framework integrating a progressive rat model of Alzheimer’s disease with human iPSC-derived neurons carrying familial AD mutations, we identify agomelatine (AGO) as a d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9d811cbf-ca7c-5d5e-849f-dced6a476996
DOI
10.64898/2026.01.17.700104
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer’s modelsDOI 10.64898/2026.01.17.700104
Select a neighboring publication to make it the new centre.